Tuesday, March 23, 2021 4:29:32 PM
Dr Chang is listed as the CEO as of an article from 2020
They renewed Patents very recently
They're a MicroCap very small Biotech that is likely barely operating or is a tax shelter for Dr Chang
Supposedly, and I can't confirm this , they are currently "working on" molecules but other bigger Biotechs are working on the same ones.
The consensus is that they renewed patents to get the whole MultiCell package ready to sell to a larger Biotech that just wants these Toll Cell Receptor patents. A big Biotech could probably just buy MCET without even breaking a sweat.
I'm only 500,000 shares deep so this is a gamble for me. If it tanks I'll be ok lol
Do your Due Diligence and if you don't like what you see then don't go in.
Some people here are 25milly shares in.
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM